Home › Triple-Negative Breast Cancer › Oregon › Eugene
Triple-Negative Breast Cancer clinical trials in Eugene, OR
3 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Eugene (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
RecruitingPhase 3
- Willamette Valley Cancer Institute and Research Center, Eugene
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RecruitingPhase 2/3
- Willamette Valley Cancer Institute, Eugene
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- USOR Oncology Associates of Oregon, P.C., Eugene
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Atlanta, GA20 studies
- Arlington, VA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in Eugene
- Non-Small Cell Lung Cancer13 studies
- Ovarian Cancer9 studies
- Endometrial Cancer8 studies
- Breast Cancer7 studies
- Chronic Lymphocytic Leukemia6 studies
- Multiple Myeloma6 studies
- Metastatic Cancer6 studies
- Cancer (all types)6 studies
- Drug Use and Addiction5 studies
- Lung Cancer5 studies
- Macular Degeneration5 studies
- Obesity4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.